Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?

·3 min read

In this Motley Fool Live video recorded on Oct. 6, Motley Fool contributors Keith Speights and Brian Orelli discuss how big the market opportunity might be for AstraZeneca's COVID-19 therapy. Keith Speights: On Tuesday, AstraZeneca filed for Emergency Use Authorization for its COVID-19 antibody therapy.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting